CHRIS TALPAS is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Mar 2021: MediPharm Labs Corp. (Barrie, Ontario, Canada (as filed: A6) — industry reported as "Other" — 2021; 3 investors reported).
What this means One deal on file with the SEC, filed Mar 2021. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside AHMED SHEHATA (1 shared filing), BRETT MOON (1 shared filing), CHRIS HALYK (1 shared filing), CHRIS TAVES (1 shared filing), GEOFF MARR (1 shared filing) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around CHRIS. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for CHRIS TALPAS and found 2 differences: CHRIS TALPAS appears on 1 deal that stopped filing before reaching its target; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.